TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 122 filers reported holding TANGO THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $521 | -56.5% | 65,600 | -45.8% | 0.00% | -50.0% |
| Q4 2023 | $1,198 | +178.6% | 121,000 | +216.8% | 0.00% | +100.0% |
| Q3 2023 | $430 | +64.8% | 38,200 | -51.5% | 0.00% | – |
| Q2 2023 | $261 | +8.3% | 78,700 | +29.2% | 0.00% | – |
| Q1 2023 | $241 | +31.7% | 60,900 | +140.7% | 0.00% | – |
| Q4 2022 | $183 | -99.6% | 25,300 | +125.9% | 0.00% | – |
| Q3 2022 | $41,000 | – | 11,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,201,475 | $164,748,656 | 81.48% |
| Mass General Brigham, Inc | 354,192 | $3,038,967 | 14.80% |
| Nextech Invest Ltd. | 5,533,980 | $47,481,548 | 7.99% |
| Boxer Capital, LLC | 8,198,642 | $70,344,348 | 3.70% |
| EcoR1 Capital, LLC | 13,330,736 | $114,377,715 | 3.50% |
| Braslyn Ltd. | 26,961 | $231,325 | 2.77% |
| Bain Capital Life Sciences Investors, LLC | 2,892,663 | $24,819,049 | 2.72% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 115,571 | $991,599 | 1.25% |
| Samsara BioCapital, LLC | 630,000 | $5,405,400 | 1.13% |
| Southpoint Capital Advisors LP | 5,276,699 | $45,274,077 | 1.13% |